The effect of lorcainide on arrhythmias and survival in patients with acute myocardial infarction: an example of publication bias

References

Page 1

	Year	Citations
Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial Infarction New England Journal of Medicine Cardiovascular ToxicityHeart FailureActive DrugCardiovascular DiseaseMedicine	1989	3.3K
Effect of the Antiarrhythmic Agent Moricizine on Survival after Myocardial Infarction New England Journal of Medicine	1992	1K
The cardiac arrhythmia suppression trial: First CAST … then CAST-II H.Leon Greene, Dan M. Roden, Richard J. Katz, Journal of the American College of Cardiology First Cast …Structural Heart DiseaseCardiovascular DiseaseArrhythmiaCardiac Electrophysiology	1992	138
CAST and beyond Implications of the Cardiac Arrhythmia Suppression Trial M. Akhtar, G. Breilhardt, A. John Camm, European Heart Journal Cardiogenic ShockCardiac AnaesthesiaItaly CorrespondenceCardiovascular DiseaseItaly Search	1990	53
Clinical experience with lorcainide (R 15 889), a new anti-arrhythmic drug. Hugo Kesteloot, Roland Stroobandt PubMed Heart FailureCardiac AnaesthesiaCardiovascular PharmacologyPharmacotherapyRepetitive Auricular Tachycardia	1977	41
Disposition and antiarrhythmic effect of lorcainide. Ulrich Klotz, P Müller-Seydlitz, P. Heimburg PubMed Heart FailureCardiac AnaesthesiaCardiovascular PharmacologyPharmacotherapyExperimental Pharmacology	1979	31
ANTIFIBRILLATORY EFFICACY OF ENCAINIDE, LORCAINIDE AND ORG 6001 COMPARED WITH LIGNOCAINE IN ISOLATED HEARTS OF RABBITS AND GUINEA‐PIGS Abdulrahman A. Almotrefi, Joshua Baker British Journal of Pharmacology	1981	19
Lessons from the cardiac arrhythmia suppression trial. Chris Garratt, D. E. Ward, A. John Camm BMJ Cardiovascular DiseaseCardiovascular PharmacologyCardiac ElectrophysiologyElectrophysiologyCardiac Arrest	1989	13

Page 1